Harrow reports iheezo® patient discomfort results after intravitreal injections
Harrow announces iheezo® patient-reported discomfort data following intravitreal injections, citing lower discomfort at all post-injection assessments and statistically significant differences versus comparator at every time point.
HROW Harrow announces iheezo® data in patient-reported discomfort following intravitreal injections Harrow - iheezo Associated with lower patient-reported discomfort at all post-injection assessments - Single-center, investigator-initiated study demonstrated statistically significant differences favoring iheezo at every measured time point